Reuters logo
BRIEF-Ampliphi biosciences reports ‍cash and cash equivalents as of Sept 30 totaled $7.7 mln
November 14, 2017 / 9:10 PM / a month ago

BRIEF-Ampliphi biosciences reports ‍cash and cash equivalents as of Sept 30 totaled $7.7 mln

Nov 14 (Reuters) - Ampliphi Biosciences Corp

* Ampliphi Biosciences reports third quarter 2017 financial results and business highlights

* Ampliphi Biosciences Corp - ‍Cash and cash equivalents as of September 30, 2017 totaled $7.7 million

* Ampliphi Biosciences Corp - ‍Anticipates current financial resources will provide sufficient cash to fund operations until mid-2018​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below